Arc Bio LLC
Arc Bio LLC develops the Omni ID mNGS platform — reagent kits, a cloud-based bioinformatics WebApp (Lumens), and custom metagenomics services — for clinical microbiology, research, and biopharma labs performing broad-range microbial detection on Illumina sequencers.
- Company typePrivate
- Founded2018
- HeadquartersMenlo Park, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Arc Bio LLC does
Arc Bio LLC is a privately held life sciences company founded in July 2018 and headquartered in Menlo Park, California, with an additional office in the Metro Boston area. The company operates as a subsidiary of EdenRoc Sciences, a holding company whose portfolio also includes Cantata Bio and Dovetail Genomics. Arc Bio develops metagenomic next-generation sequencing (mNGS) tools targeting infectious disease applications, with its flagship platform branded as Omni ID™ (and previously marketed as the Galileo Pathogen Solution and Galileo ONE).
The company's product suite consists of (i) SeqPrep reagent kits — including ExoBiome-DNA for microbial enrichment, Standards and Controls for QC, and DNA/RNA library prep reagents configurable for up to 24 libraries; (ii) the Lumens cloud-based WebApp, powered by a proprietary graph-based sequence aligner and signal-scoring system that automates microbial detection and QC reporting; and (iii) customizable APIs for programmatic access. The platform is compatible with Illumina NextSeq and NovaSeq sequencers, claims sample-to-results in under 30 hours, detects more than 1,400 microbial species without targeted primers/probes, and is positioned as covering more than 99% of known human pathogens from a single sample across parallel DNA and RNA workflows. Arc Bio also offers custom metagenomics services, biomarker discovery, and workflow consulting for biopharma and research customers.
Arc Bio generates revenue through sale of reagent kits (unit pricing, pay-as-you-go), Lumens software tokens bundled with kits or sold separately (recurring software usage), and professional services for bespoke workflow development. Go-to-market is primarily direct sales via the company website and phone/email contact, supplemented by conference participation (e.g., IDWeek, Conference Amp) and peer-reviewed publication-driven scientific marketing. The platform targets clinical microbiology labs, academic and commercial research labs, and biopharma companies, and is currently sold as a research-use-only (RUO) product.
Arc Bio LLC firmographics
Firmographics- Name
- Arc Bio LLC
- Legal name
- Arc Bio LLC
- Website
- https://arcbio.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Arc Bio LLC develops the Omni ID mNGS platform — reagent kits, a cloud-based bioinformatics WebApp (Lumens), and custom metagenomics services — for clinical microbiology, research, and biopharma labs performing broad-range microbial detection on Illumina sequencers.
- Ownership category
- akta.pro rank
Arc Bio LLC industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industries
- Microbiome & Metagenomics Services (HLAGANAH), Laboratory-Based Surveillance & Genomic Epidemiology (WGS/NGS) (HLAJABAC)
Keywords
Where Arc Bio LLC is headquartered
LocationHeadquarters
- HQ city
- Menlo Park
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Arc Bio LLC business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- mNGS Reagent Kits: Sale of reagent kits for mNGS library preparation including SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA, and Standards. Kits are available in multiple configurations to supplement existing workflows or deploy complete Omni ID solutions. Each kit processes up to 24 libraries.
- Lumens Software Tokens: Cloud-based WebApp processing credits (Lumens Tokens) for library analysis. Tokens are included with SeqPrep reagent kits or available separately. Provides file processing, QC analysis, and microbial detection reporting.
- Custom NGS Services: Bespoke wet lab and dry lab services enabling partners to augment capabilities or develop in-house metagenomics solutions. Includes custom metagenomics solutions, biomarker discovery, workflow establishment counseling, and automation services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Omni ID reagent kits available in multiple configurations for supplementing existing workflows or deploying complete solutions |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels5 records
Arc Bio LLC product offering
Product offeringCore offering
Arc Bio LLC provides the Omni ID™ metagenomic Next-Generation Sequencing (mNGS) platform, which combines reagent kits for sample and library preparation (SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA, and Standards) with the Lumens cloud-based WebApp for automated microbial detection and QC reporting. The platform enables clinical and research labs to perform unbiased, broad-range microbial detection of over 1,400 species from a single sample without targeted primers/probes, with sample-to-results in under 30 hours on compatible Illumina sequencers.
Product overview
Arc Bio LLC offers the Omni ID™ mNGS platform, a comprehensive metagenomic Next-Generation Sequencing solution consisting of the core Omni ID™ Platform, SeqPrep reagent kits (including ExoBiome-DNA for microbial enrichment and Standards/Controls for quality assurance), and the Lumens cloud-based bioinformatics WebApp for automated microbial detection and reporting. The platform provides sample-to-results in under 30 hours, detecting over 1,400 species of microorganisms from a single sample without need for targeted primers/probes. Arc Bio also offers custom metagenomics services, biomarker discovery, and workflow establishment consulting to support research, clinical, and biopharma applications.
Differentiator
Problem solved
Functional benefit
Brands
- Omni ID™: Proprietary target enrichment platform for next-generation sequencing applications.
- Galileo ONE
- Lumens
Products and services
- Omni ID™ Platform Metagenomic NGS (mNGS) platform enabling broad-range, single-test, multiple-indication microbial detection with flexible deployed capability for clinical and research labs. Detects over 1,400 species without targeted primers/probes, with sample-to-results in under 30 hours on compatible Illumina sequencers.
- Omni ID™ SeqPrep Kit-based sample preparation reagents for NGS library prep, including SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA for microbial enrichment, Standards and Controls for quality metrics, and barcode adapters for multiplexing up to 24 libraries per kit. Each kit processes up to 24 libraries.
- Omni ID™ Lumens Cloud-based mNGS bioinformatics WebApp that automates microbial sequence detection, QC analysis, and reporting with proprietary graph-based sequence alignment. Provides file processing, QC analysis, and microbial detection reporting through Lumens Tokens (processing credits) that are included with SeqPrep reagent kits or available separately, with access also available via customizable APIs.
- Custom Metagenomics Services Bespoke wet lab and dry lab services enabling partners to augment capabilities or develop in-house metagenomics solutions across research, healthcare, diagnostics, and biopharma applications, including custom workflow development, validation, automation, and shipping of customized solutions.
- Biomarker Discovery Services Services for biomarker discovery using metagenomics data to aid in patient selection, early detection, disease monitoring, and prediction of treatment efficacy.
- Workflow Establishment Consulting Counsel on establishing metagenomic workflows, including quality metrics, software solutions, and lab setup services.
Quantifiable outcome
- Sample-to-results in less than 30 hours
- +2 more outcomes
Companies that use Arc Bio LLC
Customer profileSegments3 records
Ideal customer profiles3 records
Arc Bio LLC technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature6 records
Arc Bio LLC partnerships and signals
Strategic signalScale indicators3 records
Recent moves4 records
Expansion highlights4 records
Arc Bio LLC competitors and assessment
Company assessmentDirect peers
- Karius: Karius offers a clinical mNGS blood test for infectious disease diagnostics, the most direct competitor to Arc Bio's Omni ID platform. Both target broad pathogen detection from liquid samples such as plasma, addressing the same hospital microbiology use cases.
- CosmosID: CosmosID provides a curated microbial genomics database and cloud-based bioinformatics for mNGS analysis, directly comparable to Arc Bio's Lumens reference database and graph-based aligner approach.
Broad incumbents
- Illumina: Illumina acquired IDbyDNA and is a broad incumbent in sequencing and metagenomics, while also being the platform on which Arc Bio's Omni ID runs. It offers overlapping DRAGEN metagenomics pipelines and is both a critical partner and a competitive threat.
- bioMérieux: bioMérieux is a major clinical microbiology and in-vitro diagnostics incumbent expanding into genomics-based pathogen detection, overlapping with Arc Bio's clinical microbiology lab use cases.
- Qiagen: Qiagen offers sample-preparation kits (QIAamp, QIAseq) plus CLC Genomics Workbench bioinformatics, spanning both halves of Arc Bio's wet-lab + cloud-software stack for molecular microbiology and genomics labs.
- Thermo Fisher Scientific: Thermo Fisher provides Ion Torrent sequencing, microbiology reagents, and bioinformatics tools that overlap with Arc Bio's mNGS workflow, serving similar clinical and research customers.
- Roche Diagnostics: Roche is a major IVD incumbent with microbiology and molecular diagnostics franchises, representing a potential clinical channel competitor as hospitals consolidate infectious-disease testing around large diagnostics vendors.
Emerging players
- DNASTAR: DNASTAR provides genomics analysis software (Lasergene) used for sequence assembly and microbial analysis, comparable to Arc Bio's Lumens as a sequence analysis and interpretation platform for research and clinical labs.
- Clear Labs: Clear Labs offers an automated NGS-based pathogen detection platform for food safety and clinical microbiology, comparable as an emerging metagenomics play targeting routine lab adoption of sequencing workflows.
- Caribou Biosciences (now part of the public clinical mNGS ecosystem via T2 Biosystems adjacency): T2 Biosystems provides rapid molecular diagnostics for infectious disease, a comparable emerging player in the clinical microbiology space where speed-to-result and broad detection are key value drivers, similar to Arc Bio's <30-hour mNGS positioning.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Arc Bio LLC social profiles
Digital presenceArc Bio LLC financial estimates
Financial estimateRevenue estimate
Valuation estimate
Arc Bio LLC leadership team
Management profileNumber of profiles
Profiles5 records
Arc Bio LLC funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Arc Bio LLC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Arc Bio LLC
What does Arc Bio LLC do?
Arc Bio LLC provides the Omni ID™ metagenomic Next-Generation Sequencing (mNGS) platform, which combines reagent kits for sample and library preparation (SeqPrep-DNA, SeqPrep-RNA, ExoBiome-DNA, and Standards) with the Lumens cloud-based WebApp for automated microbial detection and QC reporting. The platform enables clinical and research labs to perform unbiased, broad-range microbial detection of over 1,400 species from a single sample without targeted primers/probes, with sample-to-results in under 30 hours on compatible Illumina sequencers.
Is Arc Bio LLC a public or private company?
Arc Bio LLC is a private company. It is classified as corporate owned and is currently operating.
When was Arc Bio LLC founded?
Arc Bio LLC was founded in 2018. It employs 11 to 50 people.
Where is Arc Bio LLC based?
Arc Bio LLC is headquartered in Menlo Park, United States, in the North America region.
How does Arc Bio LLC make money?
Three revenue lines are on record. mNGS Reagent Kits are the primary driver. The others are lumens Software Tokens and custom NGS Services.
Who are Arc Bio LLC's main competitors?
Direct peers on record are Karius and CosmosID. Broad incumbents are Illumina, bioMérieux, Qiagen, Thermo Fisher Scientific and Roche Diagnostics. Emerging players are DNASTAR, Clear Labs and Caribou Biosciences (now part of the public clinical mNGS ecosystem via T2 Biosystems adjacency).
Does Arc Bio LLC have an API?
Yes. Customizable APIs are available for the Omni ID platform. Access and library processing tokens for Omni ID Lumens are included through the user-friendly web app and customizable APIs.
What industry is Arc Bio LLC in?
Arc Bio LLC's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAH, Microbiome & Metagenomics Services. Its NAICS code is 541714 and its SIC code is 8731.